Zoetis Inc.

ZTS Health Care · Pharmaceuticals & Biotechnology

Latest period 2026-06-30 · 35 filings on record

Quarterly TTM Annual

8Q 3Y 5Y 10Y MAX

TTM 24-09 → TTM 26-06 8 TTM POINTS

SHOWING Trailing twelve months — each point sums the four quarters ending there.

Ranked against Health Care · 51 peers

Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-30.

Growth 14th pct

▼−48 over range · as of 2026-06-30

Revenue -0.2% YoY, earnings -4.8% YoY · sector avg 66

Quality 81st pct

▼−2 over range · as of 2026-06-30

28.0% net margin, 84% return on equity, 24% free-cash-flow margin, profitable in 8 of last 8 quarters · sector avg 45

Safety 70th pct

▼−14 over range · as of 2026-06-30

Net debt 1.9x EBITDA, 3.1x current ratio · sector avg 59

OVERVIEWvs prior TTM Δ

Trailing twelve months · ending 2026-06-30 · green = improving · click a row to chart it

Revenue $9.5B −0.1% Gross margin 71.7% −0.1pp Operating margin — — Net margin 27.7% −0.3pp CHARTED Net income $2.6B −1.3%

Debt / equity 2.87 +2.7%

EPS (diluted) — — EBITDA — —

Filings

TTM 24-09 → TTM 26-06 · following the period bar 12 match

ALL 10-K 10-Q Q1 Q2 Q3 FY SORT NEWEST ↓

Filings by fiscal year and period
Year	Q1	Q2	Q3	FY
2026	10-Q Q1 2026	10-Q Q2 2026	no filing	no filing
2025	10-Q Q1 2025	10-Q Q2 2025	10-Q Q3 2025	10-K FY 2025
2024	10-Q Q1 2024	10-Q Q2 2024	10-Q Q3 2024	10-K FY 2024
2023	no filing	no filing	no filing	10-K FY 2023

10-Q Q2 2026 2026-08-06 Pro → 10-Q Q1 2026 2026-05-07 Pro → 10-K FY 2025 2026-02-12 Pro → 10-Q Q3 2025 2025-11-04 Pro → 10-Q Q2 2025 2025-08-05 Pro → 10-Q Q1 2025 2025-05-06 Pro →

All 12 filings

10-K FY 2024 2025-02-13 Pro → 10-Q Q3 2024 2024-11-04 Pro → 10-Q Q2 2024 2024-08-06 Pro → 10-Q Q1 2024 2024-05-02 Pro → 10-K FY 2023 2024-02-13 Pro → 10-Q/A Q2 2019-08-09 Pro →

Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans

Trends

Trailing twelve months, rolling one quarter at a time

Revenue

Latest$9.5B vs prior TTM−0.1% Periods8

Revenue by period
Period	Period end	Revenue
TTM 24-09	2024-09-30	$9.2B
TTM 24-12	2024-12-31	$9.3B
TTM 25-03	2025-03-31	$9.3B
TTM 25-06	2025-06-30	$9.4B
TTM 25-09	2025-09-30	$9.4B
TTM 25-12	2025-12-31	$9.5B
TTM 26-03	2026-03-31	$9.5B
TTM 26-06	2026-06-30	$9.5B

Net income

Latest$2.6B vs prior TTM−1.3% Periods8

Net income by period
Period	Period end	Net income
TTM 24-09	2024-09-30	$2.4B
TTM 24-12	2024-12-31	$2.5B
TTM 25-03	2025-03-31	$2.5B
TTM 25-06	2025-06-30	$2.6B
TTM 25-09	2025-09-30	$2.6B
TTM 25-12	2025-12-31	$2.7B
TTM 26-03	2026-03-31	$2.7B
TTM 26-06	2026-06-30	$2.6B

Net margin

Latest27.7% vs prior TTM−0.3pp Periods8

Net margin by period
Period	Period end	Net margin
TTM 24-09	2024-09-30	26.6%
TTM 24-12	2024-12-31	26.9%
TTM 25-03	2025-03-31	26.9%
TTM 25-06	2025-06-30	27.6%
TTM 25-09	2025-09-30	28.0%
TTM 25-12	2025-12-31	28.2%
TTM 26-03	2026-03-31	28.0%
TTM 26-06	2026-06-30	27.7%

ZOOM

TTM 12-12 TTM 26-06

Grade history

Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.

Growth 14 Quality 81 Safety 70

Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100

Grade history by period
Period	Period end	Growth	Quality	Safety
TTM 24-09	2024-09-30	62	83	84
TTM 24-12	2024-12-31	45	80	69
TTM 25-03	2025-03-31	35	82	63
TTM 25-06	2025-06-30	45	83	61
TTM 25-09	2025-09-30	27	79	73
TTM 25-12	2025-12-31	29	83	74
TTM 26-03	2026-03-31	27	81	72
TTM 26-06	2026-06-30	14	81	70